Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years
- PMID: 33441799
- PMCID: PMC7806847
- DOI: 10.1038/s41598-020-80222-3
Evaluation of Acanthamoeba keratitis cases in a tertiary medical care centre over 21 years
Abstract
To report on Acanthamoeba keratitis cases in a tertiary university eye-hospital in Graz, Austria, over a 21-year period. Retrospective study. Parameters included demographics, diagnostics, clinical courses, medical therapies, surgical interventions, secondary complications, and best spectacle-corrected visual acuity (BSCVA). Patient records for 44 eyes of 42 patients were analysed; 2 bilateral infections. Mean age at presentation was 31 ± 13 (16-65) years; contact lenses were used in 41 of 44 eyes (93.2%). Symptoms at initial presentation were mainly pain (41/43, 95.3%) and photophobia (16/43, 37.2%). Most frequent morphological findings were stromal infiltrates (30/44, 68.2%). Diagnosis was mainly confirmed by smears (40/42, 95.2%) and polymerase chain reaction (8/42, 19%). Antiamoebic treatment comprised biguanides and diamidines. Penetrating keratoplasty was performed in 10/44 (22.7%) eyes. Median time from symptom onset to initial visit was 2 (0-26) weeks; median follow-up was 30 (2-1008) weeks. BSCVA improved in 23/36 (63.9%) eyes, remained unchanged in 6/36 (16.7%) eyes and deteriorated in 7/36 (19.4%) eyes. Acanthamoeba keratitis predominantly occurs in young contact lens wearers. Diagnosis should be considered in patients with pain and stromal infiltrates. In the majority of cases, BSCVA can be improved. Early diagnosis and adequate treatment should be implemented to prevent complications.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Delayed diagnoses of Acanthamoeba keratitis at a tertiary care medical centre.Acta Ophthalmol. 2021 Dec;99(8):916-921. doi: 10.1111/aos.14792. Epub 2021 Feb 14. Acta Ophthalmol. 2021. PMID: 33583148
-
Analysis from a year of increased cases of Acanthamoeba Keratitis in a large teaching hospital in the UK.Cont Lens Anterior Eye. 2019 Oct;42(5):506-511. doi: 10.1016/j.clae.2019.04.009. Epub 2019 Apr 22. Cont Lens Anterior Eye. 2019. PMID: 31018907
-
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis.Br J Ophthalmol. 2000 Oct;84(10):1103-8. doi: 10.1136/bjo.84.10.1103. Br J Ophthalmol. 2000. PMID: 11004092 Free PMC article.
-
[Treatment of Acanthamoeba keratitis: possibilities, problems, and new approaches].Wien Klin Wochenschr. 2003;115 Suppl 3:10-7. Wien Klin Wochenschr. 2003. PMID: 15508774 Review. German.
-
The epidemic of Acanthamoeba keratitis: where do we stand?Cornea. 1998 Jan;17(1):3-10. doi: 10.1097/00003226-199801000-00001. Cornea. 1998. PMID: 9436873 Review.
Cited by
-
Acanthamoeba Keratitis: A Single-Institution Series of Four Cases With Literature Review.Cureus. 2022 Jan 11;14(1):e21112. doi: 10.7759/cureus.21112. eCollection 2022 Jan. Cureus. 2022. PMID: 35165570 Free PMC article.
-
The Anti-Amoebic Activity of a Peptidomimetic against Acanthamoeba castellanii.Microorganisms. 2022 Nov 30;10(12):2377. doi: 10.3390/microorganisms10122377. Microorganisms. 2022. PMID: 36557630 Free PMC article.
-
Acanthamoeba keratitis: Experience from a tertiary eye care center in North India.Trop Parasitol. 2022 Jul-Dec;12(2):119-123. doi: 10.4103/tp.tp_16_22. Epub 2022 Nov 24. Trop Parasitol. 2022. PMID: 36643983 Free PMC article.
-
Acanthamoeba keratitis - A review.Indian J Ophthalmol. 2024 Apr 1;72(4):473-482. doi: 10.4103/IJO.IJO_2627_23. Epub 2024 Mar 8. Indian J Ophthalmol. 2024. PMID: 38454853 Free PMC article. Review.
-
Differentiation of acanthamoeba keratitis from other non-acanthamoeba keratitis: Risk factors and clinical features.PLoS One. 2024 Mar 12;19(3):e0299492. doi: 10.1371/journal.pone.0299492. eCollection 2024. PLoS One. 2024. PMID: 38470877 Free PMC article.
References
-
- Centers for Disease Control and Prevention (CDC) Acanthamoeba keratitis multiple states, 2005–2007. MMWR Morb. Mortal. Wkly. Rep. 2007;56:532–534. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources